Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies
出版年份 2017 全文链接
标题
Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies
作者
关键词
Docetaxel, Imatinib, Sunitinib, Topotecan, Dasatinib
出版物
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
Volume 42, Issue 6, Pages 915-933
出版商
Springer Nature
发表日期
2017-04-03
DOI
10.1007/s13318-017-0411-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
- (2016) Nuggehally R. Srinivas CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans
- (2016) M. Bauer et al. JOURNAL OF NUCLEAR MEDICINE
- ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model
- (2016) R. K. Mittapalli et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors
- (2015) Elizabeth Fox et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function
- (2015) Jonas Tallkvist et al. CELL BIOLOGY AND TOXICOLOGY
- P-Glycoprotein (ABCB1) Limits the Brain Distribution of YQA-14, a Novel Dopamine D3 Receptor Antagonist
- (2015) Fei Liu et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors
- (2015) Ping Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Breast Cancer Resistance Protein and P-Glycoprotein Influence In Vivo Disposition of 11C-Erlotinib
- (2015) A. Traxl et al. JOURNAL OF NUCLEAR MEDICINE
- Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer
- (2015) T. Sugano et al. MOLECULAR CANCER THERAPEUTICS
- P-glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain Disposition and Oral Availability of the Novel Taxane Cabazitaxel (Jevtana) in Mice
- (2015) Seng Chuan Tang et al. MOLECULAR PHARMACEUTICS
- Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir
- (2015) Zuzana Neumanova et al. REPRODUCTIVE TOXICOLOGY
- Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation
- (2014) J J M A Hendrikx et al. BRITISH JOURNAL OF CANCER
- Convallatoxin: A new P-glycoprotein substrate
- (2014) Elnaz Gozalpour et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Estimation of the Unbound Brain Concentration of P-Glycoprotein Substrates or Nonsubstrates by a Serial Cerebrospinal Fluid Sampling Technique in Rats
- (2014) T. Thanga Mariappan et al. MOLECULAR PHARMACEUTICS
- Role of P-Glycoprotein on the Brain Penetration and Brain Pharmacodynamic Activity of the MEK Inhibitor Cobimetinib
- (2014) Edna F. Choo et al. MOLECULAR PHARMACEUTICS
- Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
- (2014) Michael R. Jablonski et al. Annals of Clinical and Translational Neurology
- Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo
- (2013) Jian Shi et al. ACTA PHARMACOLOGICA SINICA
- Role of P-Glycoprotein in the Distribution of the HIV Protease Inhibitor Atazanavir in the Brain and Male Genital Tract
- (2013) Kevin R. Robillard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias
- (2013) Robert O’Connor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues
- (2013) F. Lin et al. CLINICAL CANCER RESEARCH
- Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar
- (2013) Seng Chuan Tang et al. INTERNATIONAL JOURNAL OF CANCER
- P-glycoprotein Inhibition Increases the Brain Distribution and Antidepressant-Like Activity of Escitalopram in Rodents
- (2013) Fionn E O'Brien et al. NEUROPSYCHOPHARMACOLOGY
- Transport Inhibition of Digoxin Using Several Common P-gp Expressing Cell Lines Is Not Necessarily Reporting Only on Inhibitor Binding to P-gp
- (2013) Annie Albin Lumen et al. PLoS One
- Investigational ABC transporter inhibitors
- (2012) Marco Falasca et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors
- (2012) Mukul Minocha et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib
- (2012) Mukul Minocha et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oral Availability and Brain Penetration of the B-RAFV600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar
- (2012) Selvi Durmus et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetics of Single Ascending Doses of the P-Glycoprotein Inhibitor Tariquidar in Healthy Subjects
- (2012) M. Bauer et al. PHARMACOLOGY
- Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
- (2012) Britta Stordal et al. PLoS One
- Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats
- (2011) Shrikant Patil et al. BIOMEDICAL CHROMATOGRAPHY
- Interaction of innovative small molecule drugs used for cancer therapy with drug transporters
- (2011) K Mandery et al. BRITISH JOURNAL OF PHARMACOLOGY
- Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration
- (2011) Seng Chuan Tang et al. INTERNATIONAL JOURNAL OF CANCER
- Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2011) H. Shen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
- (2011) Amanda J O'Neill et al. Molecular Cancer
- Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers
- (2011) Donald W. Miller et al. NEUROUROLOGY AND URODYNAMICS
- Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography
- (2011) Tomoteru Yamasaki et al. NUCLEAR MEDICINE AND BIOLOGY
- Pharmacokinetic Modeling to Assess Factors Affecting the Oral Bioavailability of the Lactone and Carboxylate Forms of the Lipophilic Camptothecin Analogue AR-67 in Rats
- (2011) Eyob D. Adane et al. PHARMACEUTICAL RESEARCH
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999
- (2010) L. D. Cripe et al. BLOOD
- The Bioflavonoid Kaempferol Is an Abcg2 Substrate and Inhibits Abcg2-Mediated Quercetin Efflux
- (2010) G. An et al. DRUG METABOLISM AND DISPOSITION
- The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain
- (2010) S. Agarwal et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment
- (2009) J. S. Lagas et al. CLINICAL CANCER RESEARCH
- Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET
- (2009) Claudia Kuntner et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials
- (2009) Nicola Antonio Colabufo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comparison of bidirectional lamivudine and zidovudine transport using MDCK, MDCK–MDR1, and Caco-2 cell monolayers
- (2009) Jacqueline de Souza et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- P-glycoprotein and Breast Cancer Resistance Protein Influence Brain Distribution of Dasatinib
- (2009) Y. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using [11C]gefitinib
- (2009) Kazunori Kawamura et al. NUCLEAR MEDICINE AND BIOLOGY
- Chemosensitivity Determinants of Irinotecan Hydrochloride in Hepatocellular Carcinoma Cell Lines
- (2008) Takenori Takahata et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families
- (2008) Robert Fredriksson et al. FEBS LETTERS
- The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
- (2008) Roos L. Oostendorp et al. INVESTIGATIONAL NEW DRUGS
- ABC transporters and the accumulation of imatinib and its active metabolite CGP74588 in rat C6 glioma cells
- (2008) Xavier Declèves et al. PHARMACOLOGICAL RESEARCH
- Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters
- (2007) J A Schrickx et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search